Schering-Plough job goes to Shire Hall International

Shire Hall International has beaten off competition from two rivals to

win a global brief from pharmaceuticals giant Schering-Plough.

The agency, an arm of the WPP-owned Shire Hall Group, is tasked with

providing medical education and PR support for a pair of prescription

drugs made by Schering-Plough's cardiology division.

One is Integrilin, used by patients suffering from conditions such as

unstable angina. The other is Ezetimibe, claimed by the agency to be the

'first in a new class of cholesterol absorption inhibitors' and

currently in clinical development.

The account was won jointly with Shire Hall's US division, which will

work alongside International on the client. The business is led by Lois

Hall, the international unit's MD.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in